Laura K. Schmalbrock

Clonal evolution of acute myeloid leukemia with <i>FLT3</i>-ITD mutation under treatment with midostaurin

Laura K. Schmalbrock, Anna Dolnik, Sibylle Cocciardi et al. · Blood · 2021 · 158 citations · Full text

Medicine, Hematology, Oncology +14

Impact of<i>IDH1</i>and<i>IDH2</i>mutation detection at diagnosis and in remission in patients with AML receiving allogeneic transplantation

Marius Bill, Madlen Jentzsch, Lara Bischof et al. · Blood Advances · 2022 · 34 citations · Full text

Life Sciences, Genetics, Hematology +14

Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational study

Charlotte Thibeault, Barbara Mühlemann, Elisa T. Helbig et al. · Infection · 2021 · 31 citations · Full text

Engineering, Infectious Diseases, Hospital Medicine +13

A novel prognostic risk model for patients with refractory/relapsed acute myeloid leukemia receiving venetoclax plus hypomethylating agents

Rabia Shahswar, Razif Gabdoulline, Martin Wichmann et al. · Leukemia · 2025 · 23 citations · Full text

Medicine, Molecular Medicine, Oncology +13

Incidence and prognostic impact of ASXL2 mutations in adult acute myeloid leukemia patients with t(8;21)(q22;q22): a study of the German-Austrian AML Study Group

Nikolaus Jahn, Mridul Agrawal, Lars Bullinger et al. · Leukemia · 2017 · 20 citations

Life Sciences, Genetics, Hematology +15